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More than 90% of the 150 million new episodes of pneumonia identified per year worldwide occur in the developing countries. Most of these respiratory tract 
infections in children are due to viruses [1]. According to the World 
Health Organization (WHO), respiratory syncytial virus (RSV) is 
the leading etiological agent in 15–40% of children hospitalized 
with pneumonia or bronchiolitis in the developing world [2]. 
Globally, RSV accounts for 64 million cases and 160,000 deaths 
annually [3]. Nearly 60% of all children are infected with RSV 
within the 1st year of life and almost all by the end of 2nd year. 
RSV infection is usually limited to the upper respiratory tract 
and is characterized by profuse rhinorrhea. However, 25–40% of 
these infants may subsequently develop severe respiratory disease 
requiring hospitalization [4]. Primary respiratory infection by 
this virus increases the risk of secondary bacterial pneumonia 
and viral or bacterial coinfection in approximately 20–30% of 
episodes [5]. This results in long-term respiratory disorders such 
as abnormal pulmonary function, asthma, recurrent cough and 
bronchitis [6,7].
Studies estimating the prevalence of RSV in children 
hospitalized with severe community-acquired pneumonia (CAP) 
are limited in the literature [8]. A single study from South India 
detected viruses in 37% of the children with pneumonia. Children 
with severe CAP diagnosed as per the WHO guidelines are 
treated with intravenous antibiotics routinely. Identifying a viral 
etiological agent in such children can greatly reduce the use of 
unnecessary antibiotics, at least in hospitalized children. Thus, 
there is a felt need to study the epidemiology of CAP among 
hospitalized children in developing countries [9].
RSV is classified into groups A and B based on reactions 
with monoclonal antibodies against the fusion (F) and 
attachment glycoproteins (G). Both groups circulate within the 
community and health-care institutions and predominance of 
one over the other varies by year and geographic location [10]. 
Hence, in this study, we aimed to estimate the prevalence of RSV 
infection in children admitted with severe pneumonia and to 
correlate the clinical profile with RSV positivity. The currently 
prevalent RSV group was also analyzed.
MATERIALS AND METHODS
We undertook this analytical cross-sectional study in a tertiary 
care pediatric hospital in South India from June to December 
2016 in children 2–60 months of age hospitalized for severe 
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pneumonia. Severe CAP was diagnosed according to the WHO 
2014 guidelines in children who were symptomatic for <14 days 
and without prior hospitalization in the past 2 months. Children 
who had chest in-drawing and fast breathing were classified as 
“severe pneumonia” and those with any general danger signs 
were classified as “very severe disease”. Children in whom 
nasopharyngeal aspiration would be a contraindication such as 
history of recent nasopharyngeal surgery or epistaxis, or refusal 
of parental consent for participation were excluded.
A convenient sample size of 100 children was chosen. 
The study protocol was approved by the Institution Ethics 
Committee. After obtaining informed consent from the parents or 
the legal guardian, the detailed history, and demographic profile 
such as age, sex, and nutritional status were recorded. Detailed 
clinical examination including pulse oximetry was recorded in 
a structured format on admission. All children had chest X-ray 
taken on admission as per our hospital protocol. All children 
diagnosed with severe pneumonia were treated with intravenous 
antibiotics along with other supportive measures. The children 
were followed up till discharge/death and the final outcome was 
also recorded. The RSV-positive and RSV-negative groups were 
compared for the presence or absence of risk factors such as 
age, premature birth, low birth weight (LBW), congenital heart 
disease (CHD), and positive family history of asthma/atopy, 
clinical, and radiological findings, oxygen requirement, and 
final outcome. The symptoms such as fever (>100.2 F), coryza, 
vomiting/refusal of feeds, loose stools,- and hurried breathing 
were also compared.
Sample collection and RSV detection: A 2” sterile, 8-french 
nasogastric tube (NGT) was inserted into nasopharynx of the 
child. A volume of 1–2 ml of normal saline was instilled into the 
NGT and the same was aspirated through the tube immediately 
using a sterile syringe. The aspirate was immediately transferred 
into a sterile transport medium (Himedia, India) provided by 
the laboratory at Institute of Basic Medical Sciences (IBMS), 
Chennai. The samples were transported to the laboratory at IBMS 
for RNA extraction and processing on the same day. Viral RNA 
in nasal swab was extracted using Macherey-Nagel Viral RNA 
isolation Kit (MN, Germany). Reverse transcription was done 
using RevertAid First Strand cDNA Synthesis Kit, (Thermo 
Fisher Scientific, India), according to manufacturer’s instructions. 
Detection of RSV was done using real-time PCR assay (Qiagen, 
Germany). Cycle threshold (CT) values <35 were considered 
positive for RSV. Categorical variables were expressed as 
proportions and continuous variables were expressed as mean and 
standard deviations (SD). Statistical significance was considered 
when the p<0.05.
RESULTS
Among the 1100 children hospitalized with the severe CAP during 
the 6 months period, 843 satisfied the inclusion criteria and were 
eligible for the study. Among them, 41 were excluded for reasons 
cited above. Cases were recruited based on availability of the 
investigator to facilitate the collection and immediate transport 
of the samples. Thus, 100 children were finally recruited. 59% 
of them were infants with a male predominance (70%). The 
prevalence of RSV in the study population was 30 % (95% 
confidence interval 21–40%) with Group A RSV detected in 16 
cases (53%). The rest were RSV B, and there was no coinfection. 
The mean (SD) age of children with RSV infection (11±7 months) 
was less than that in the RSV negative group (22.6±23 months). 
There was a definite male predominance (83.3%) in the RSV 
positive (p<0.05) group.
Age<2 years was a significant risk factor for RSV infection 
(p=0.04). There was no statistical difference in the rates of 
prematurity (p=1.000) or LBW (p=1.000) between the groups 
(Table 1). However, the presence of CHD (p=0.045) and a family 
history of asthma (p=0.036) were identified as significant risk 
factors for RSV infection.
The presence of high fever (p=0.001), coryza (p=0.013), and 
vomiting/ feed refusal (p=0.04) were significant complaints in 
children with RSV infection (Table 2). Cough was significantly 
seen in the non-RSV group (p=0.039). Complaints of fast breathing 
(p=0.312) or diarrhea (p=0.266) were not statistically significant 
between the groups. Crackles on auscultation (p=0.256) and 
hypoxia (p=0.159) were comparable in both groups, whereas 
wheeze was predominant in the RSV-negative group (p=0.032).
A radiological diagnosis of bronchiolitis (p=0.0007) and 
pneumonia (p=0.0001) was significantly common in the RSV 
negative (Table 3).
Oxygen requirement was more common in the RSV-negative 
group (p=0.0252). The requirement of intravenous fluids 
between the groups was similar (p=0.650). There were no deaths 
reported in our study. The mean (SD) duration of hospital stay 
among the RSV-positive children was 5.00±2 days and negative 
children were 5.07±2.3 days and the difference was statistically 
insignificant.
DISCUSSION
In our study, 30 among 100 (30%) children hospitalized because 
of CAP were diagnosed with RSV infection. This is similar to 
other pneumonia etiology studies that had incorporated detection 
of viral markers, which show that RSV is the leading viral cause 
[2]. RT-PCR has shown improved sensitivity in the detection 
of RSV infection when compared to other methods such as 
immunofluorescence and should be used as the first choice [11,12]. 
The RSV groups A and B were almost equally distributed in our 
study (1.1:1). Although the trends of both groups tend to vary 
in geographic areas and over the years, Swamy et al. in a study 
determining the RSV subtypes in hospitalized children <5 years 
from North India had reported a 80% prevalence of RSV B [13]. 
A study from Chennai done during 2011–2014 which tested 
samples from patients with influenza-like illness and severe 
respiratory illness showed RSV A to be the predominant type 
(68%), although the age groups studied included both children 
and adults [14].
The mean age in the RSV-positive group was 11 months which 
was slightly higher than the reported mean age of 2–8 months. 
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However, in a study done in Korea, the mean age of patients was 
15 months, with most of the cases being <1 year of age [15]. In 
our study, 16 (53%) of the RSV cases were infants and almost 
87% of the cases were <2 years of age. A similar epidemiology 
was also reported by Boloursaz et al. [16]. Seasonal variation in 
the incidence of RSV could not be discerned, as the study was 
done only in the latter half of the year.
Prematurity (GA <37 weeks), LBW <2 500 g, underlying CHD 
and mother with atopic diseases are considered independent risk 
factors for RSV infection. In the present study, only underlying 
CHD and family history of asthma were identified as significant 
risk factors. This may be due to the fact that children up to 5 
years were included rather than only infants, and there are very 
few studies on risk factors for RSV infection in children beyond 
infancy [17]. Children with RSV disease were more likely to 
present with fever, rhinorrhea, and vomiting. A Mexican study 
which included children up to 18 years of age also had a similar 
finding [18]. Predominant wheeze was recorded in a third of the 
cases but was more significantly seen in the RSV negative group. 
This observation is similar to Oladokun et al. who have reported 
wheeze only in 9% of cases with RSV disease [19]. The non-RSV 
group also had significant number of children with predominant 
crackles. Hence, auscultatory findings cannot be taken as a reliable 
indicator to distinguish RSV disease from other etiological agents.
There was no correlation between hypoxia and RSV disease 
in our study. Documented hypoxia is an important indication for 
admitting a child with respiratory distress in most guidelines, 
and pulse oximetry should be part of the clinical examination of 
children presenting with pneumonia [20]. X-rays are not routinely 
recommended in children with bronchiolitis as radiological 
findings can mimic pneumonia and should not be used to determine 
the need for antibiotics. Interestingly, a radiological diagnosis 
of bronchiolitis (generalized prominence of bronchovascular 
markings in a perihilar distribution, but no confluence consolidation 
or collapse) was more common in the RSV negative group. This 
observation may be due to the predominance of non-RSV viral 
etiological agents in the other group. Interestingly, only 37% of 
the children admitted as severe pneumonia showed radiological 
evidence of pneumonia.
The present study shows the limitation of the clinical and 
radiological findings for the diagnosis of RSV infection in CAP 
cases. This is similar to the observations made by Almasri et al. 
who studied RSV infection in children with CAP more than 
2 years [21]. In a developing country like ours, identifying a definite 
etiological agent like RSV will avoid considerable economic 
burden due to prolonged hospital stay and intravenous antibiotics. 
This will also reduce the emergence of antibiotic resistance due 
to indiscriminate antibiotic use. Our study has its limitations. The 
actual prevalence in community may vary because the study was 
done in a limited number of children attending a tertiary care 
hospital. Moreover, the seasonal pattern could not be estimated as 
the study was done in the latter half of the year. The presence of 
Table 2: Clinical symptoms and signs associated with RSV disease
Variable RSV status n (%) p value Odd’s ratio (95% CI)
Positive Negative
Fever 26 (87) 37 (53) 0.001 5.8 (1.8–18.4)
Cough 24 (80) 66 (94) 0.039 0.2 (0.06 –0.9)
Running nose 25 (83) 41 (58) 0.013 3.5 (1.2–10.33)
Hurried breathing 24 (80) 51 (73) 0.312 1.5 (0.53–4.2)
Vomiting 9 (30) 9 (13) 0.040 2.9 (1.0–8.3)
Loose stools 5 (17) 7 (10) 0.266 1.8 (0.5–6.2)
Wheeze 26 (36) 46 (64) 0.032 3.4 (1.1–10.8)
Crackles 22 (28) 57 (72) 0.256 0.6 (0.2–1.7)
Hypoxia 2 (67) 1 (33) 0.159 4.9 (0.4–56.5)
RSV: Respiratory syncytial virus, CI: Confidence interval
Table 3: Comparison of radiological features in RSV positive and 
negative groups
Diagnosis based on chest 
X-ray
RSV positive 
n (% )
RSV negative 
n (%)
Bronchiolitis 22 (38) 36 (62)
Pneumonia 7 (20) 30 (80)
Normal 1 (20) 4 (80)
RSV: Respiratory syncytial virus
Table 1: Risk factors associated with RSV disease
Variable RSV status n (%) p value Odd’s ratio (95% CI)
Positive Negative
Age<2 years 26 (36) 46 (64) 0.0395 3.4 (1.1−10.8)
H/O prematurity 4 (26.6) 11 (73.3) 1.00 0.8 (0.2−2.8)
LBW 10 (31.2) 22 (68.8) 1.000 1.0 (0.4−2.7)
CHD 3 (75) 1 (25) 0.045 7.66 (0.7−76.9)
Family H/o atopy 5 (62.5) 3 (37.5) 0.036 4.5 (0.9−20)
LBW: Low birth weight, CHD: Congenital heart disease, RSV: Respiratory syncytial virus, CI: Confidence interval
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coexisting bacterial pneumonia was also not evaluated as it requires 
invasive procedures such as lung aspiration or bronchoalveolar 
lavage. Moreover, sputum culture in young children may not be 
representative of the lower respiratory tract. Since the study did 
not include critically ill children who were admitted directly in 
the pediatric intensive care unit, the indicators of severity such as 
ventilator support and mortality could not be studied.
CONCLUSION
The prevalence of RSV infection in children <60 months of age 
admitted with features of severe pneumonia in our study was nearly 
30%. If RT PCR could be used in children with severe pneumonia 
who are hospitalized, an accurate diagnosis of RSV bronchiolitis 
can be made in high percentage of children. This would limit the 
use of antibiotics in a third of children hospitalized with CAP.
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